At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Echocardiogram (diagnostic test)
- How long the study runs
- Study runs about 42 months (dates as stated)
- About the drug or intervention
- Echocardiogram — diagnostic test: Cardiac Ultrasound Scan - using an abbreviated protocol
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 65 Years and over
- Who
- All
- Number of participants
- 500
- Started
- 2023-03-14
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for heart valve diseases
- • Clinical study - 500 participants
- • Heart Valve Disease and Heart failure contribute to 25% of hospital emergency admissions while heart failure alone has become one of the most common causes for hospitalisation in people over the age of 65
Who can take part?
- • Ages 65 Years and over
- • Diagnosed with heart valve diseases
Where?
- • London - St Bartholomews Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Heart Valve Disease and Heart failure contribute to 25% of hospital emergency admissions while heart failure alone has become one of the most common causes for hospitalisation in people over the age of 65. The burden of disease is likely to be high in a multi-ethnic community but there is a paucity of data. Management of heart valve disease requires appropriate surveillance and timely surgery. Similarly heart failure management requires treatment with medications aimed at slowing prevention of symptoms and preventing premature death. The NHS long term plan priorities early detection and treatment of valve disease and heart failure in order to reduce the burden on emergency services and improve the health of the population. Diagnosis is made using cardiac ultrasound, however staff with the required skills-set are critically limited in the community. The investigators will train non-expert staff within primary care to perform abbreviated cardiac ultrasound to detect heart valve disease or heart failure. This will be opportunistic scanning to reduce healthcare footfall. All scans will be reviewed by an expert and the investigators will use the anonymised data to develop machine learning tools to begin working with academic partners to develop tools that can improve the reliability of diagnosis from ultrasound. The investigators hope to identify the proportion with the above conditions in a multi-ethnic community and assess the feasibility of developing a program where staff can be trained for community detection, streamlined referrals can be created bridging the gap between primary and secondary care, reducing hospital emergency admissions, while ensuring patients are managed optimally.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 65 Years and over
- Who can join: All genders
What the study is looking for
- ✓\- Greater or equal to 65 years old
Who cannot take part
- ✗Clinical diagnosis of Alzheimer's Disease or Vascular Dementia
- ✗Palliative Care patients.
See the full criteria
Where Is This Study? (1 UK site)
St Bartholomews Hospital
London EC1A 7BE, United Kingdom
How to Get in Touch
Nabila Laskar, MBBS
Sponsor contactCONTACT
Guy Lloyd, MBBS
Sponsor contactCONTACT